A Study of SYH2082 Injection in Healthy Participants

NCT07736404 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: SYH2082 Injection
DRUG: Placebo

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.